Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Wajnberg, Ania, Amanat, Fatima, Firpo, Adolfo, Altman, Deena R., Bailey, Mark J., Mansour, Mayce, McMahon, Meagan, Meade, Philip +10 more·2020·Science

DOI 10.1126/science.abd7728

Cited by (1,007)

Items 701–800 of 1,007

Persisting Antibody Response to SARS-CoV-2 in a Local Austrian Population
Dennis Ladage, Delia Rösgen, Clemens Schreiner, Dorothee Ladage, Christoph Adler, Oliver Harzer, Ralf J. Braun · 2021 · Frontiers in Medicine
Surviving Older Patients Show Preserved Cellular and Humoral Immunological Memory Several Months After SARS-CoV-2 Infection
Alejandra García‐Torre, Eva Bueno‐García, Rocío López‐Martínez, Beatriz Rioseras, Marco Antonio Moro‐García, Sara Alonso, Alba Lluna-González, Alejandra Sousa-Fernández, Marta Fernández-Gudin, Laura Campos-Riopedre et al. · 2021 · The Journals of Gerontology Series A
Cytidine deamination-induced perpetual immunity to SAR-CoV-2 infection is a potential new therapeutic target
Asad Ullah, Neelam Mabood, Muhammad Maqbool, Luqman Khan, Mujib Ullah · 2021 · International Journal of Medical Sciences
Analytical characterization of the SARS-CoV-2 EURM-017 reference material
James Freeman, Kalen Olson, Justin Conklin, Victoria Shalhoub, Bryan A. Johnson, Nathen E. Bopp, Diana M Fernandez, Vineet D. Menachery, Patricia V. Aguilar · 2021 · Clinical Biochemistry
Pfizer-BioNTech COVID-19 Vaccine in Gynecologic Oncology Patients: A Prospective Cohort Study
Innocenza Palaia, Giuseppe Caruso, Violante Di Donato, Annarita Vestri, Anna Napoli, Giorgia Perniola, Matteo Casinelli, Danilo Alunni Fegatelli, Roberta Campagna, Federica Tomao et al. · 2021 · Vaccines
A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019?
Claudia Maria Trombetta, Serena Marchi, Simonetta Viviani, Alessandro Manenti, Elisa Casa, Francesca Dapporto, Edmond J. Remarque, Valentina Bollati, Ilaria Manini, Giacomo Lazzeri et al. · 2022 · Human Vaccines & Immunotherapeutics
Investigation and long‐term monitoring of the presence of neutralizing antibody in patients with COVID‐19 disease of different clinical severity
S. Kaygusuz, G. Korukluoglu, Y. Coşgun, Ömer Şahin, F. Arslan · 2022 · Journal of Medical Virology
Role of serology tests in COVID-19 non-hospitalized patients: A cross-sectional study
Mohammad Taghi Haghi Ashtıani, Parisa Sadeghi Rad, Kosar Asnaashari, Alireza Shah-Hosseini, Fariba Berenji, Setareh Mamishi · 2022 · PLoS ONE
COVID-19 Antibody Detection and Assay Performance Using Red Cell Agglutination
Kshitij Srivastava, Kamille A West, Valeria De Giorgi, Michael R. Holbrook, Nicolai V. Bovin, Stephen M Henry, Willy A. Flegel · 2021 · Microbiology Spectrum
Decreased Efficiency of Neutralizing Antibodies from Previously Infected or Vaccinated Individuals against the B.1.617.2 (Delta) SARS-CoV-2 Variant
C. Diméglio, F. Hérin, Isabelle Da-Silva, Caroline Gernigon, Marion Porcheron, S. Chapuy-Regaud, J. Izopet · 2022 · Microbiology spectrum
SARS-CoV-2 multi-antigen protein microarray for detailed characterization of antibody responses in COVID-19 patients
A. Celikgil, A. Massimi, A. Nakouzi, Natalia G. Herrera, Nicholas C. Morano, James H. Lee, H. Yoon, S. Garforth, S. Almo · 2022 · bioRxiv
Serological Testing for COVID-19 Disease: Moving the Field of Serological Surveillance Forward
Abdulla A. Damluji, Devin Rajan, Amanda N Haymond, Christopher R. deFilippi · 2021 · The Journal of Applied Laboratory Medicine
A longitudinal follow-up of COVID-19 patients in the convalescent phase showed recovery in radiological results, the dynamics of lymphocytes, and a decrease in the level of IgG antibody: a single-centre, observational study
Ziqi Wang, Li Yang, Yi Chen, Zhiwei Xu, Hui Wang, Xiaoju Zhang · 2021 · Journal of Thoracic Disease
Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency – Three consecutive cases and review of the literature
Marcial Delgado‐Fernández, Gracia Mar García-Gemar, Ana Paula Fuentes, Manuel Isidro Muñoz-Pérez, Salvador Oyonarte, Ignacio Ruiz-García, Jesica Martín Carmona, Jaime Sanz‐Cánovas, Manuel Ángel Castaño-Carracedo, José María Reguera-Iglesias et al. · 2022 · Enfermedades infecciosas y microbiologia clinica (English ed )
Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study
Fabio Borgonovo, Matteo Passerini, Marco Piscaglia, Valentina Morena, Andrea Giacomelli, Letizia M Oreni, Gianfranco Dedivitiis, A. Lupo, Stefania Falvella, Maria Vittoria Cossu et al. · 2021 · Journal of Infection
Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020–21
L. Pezzati, A. Giacomelli, D. Mileto, F. Conti, Gloria Gagliardi, A. Rizzo, Laura Milazzo, M. Schiuma, A. Covizzi, M. Siano et al. · 2021 · medRxiv
Safety and Efficacy of Preventative COVID Vaccines: The StopCoV Study
Sharon Lynn Walmsley, Leah Szadkowski, Bradly G. Wouters, Rosemarie Clarke, Karen Colwill, Paula A. Rochon, Michael Brudno, Rizani Ravindran, Janet Raboud, Allison McGeer et al. · 2022 · SSRN Electronic Journal
Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2
K. Vanshylla, V. Di Cristanziano, Franziska Kleipass, Felix Dewald, P. Schommers, L. Gieselmann, H. Gruell, M. Schlotz, M. Ercanoglu, Ricarda Stumpf et al. · 2021 · bioRxiv
Homologous and heterologous serological response to the N‐terminal domain of SARS‐CoV‐2 in humans and mice
Huibin Lv, O. Tsang, Ray T. Y. So, Yi-Quan Wang, M. Yuan, Hejun Liu, Garrick K. Yip, Q. Teo, Yihan Lin, Wei-Wen Liang et al. · 2021 · European Journal of Immunology
Development of at-home sample collection logistics for large-scale seroprevalence studies
Aishani V. Aatresh, Kate Cummings, Hilary Gerstein, Christopher S. Knight, Andreas Limberopolous, Megan A. Stasi, Alice S. Bedugnis, Kenneth A. Somberg, Camila Tenorio França, Michael Joseph Mina · 2021 · PLoS ONE
SARS-CoV-2 antibody response after BNT162b2 mRNA vaccine in healthcare workers: Nine-month of follow-up
Franco Mastroianni, Pietro Guida, Grazia Bellanova, Edy Valentina De Nicolò, Giulia Righetti, Maurizio Formoso, Fabrizio Celani · 2022 · Vaccine X
SARS-COV-2 IgG specific antibodies persistence in recovered COVID-19 individuals and its association with severity and time of illness
Abdol Sattar Pagheh, Arash Ziaee, Khadijeh Abrari Romenjan, Fatemeh Mohammad Rezaei, Babak Bahman, Effat Alamzadeh, Samira Elhamirad, Masood Ziaee · 2023 · New Microbes and New Infections
A systematic review of rapid SARS-CoV-2 detection methods for mitigating future outbreaks of emerging or historical pathogens
Yuer Wang, Jiteng Xiao, Junqing Wei, Yadan Peng, Mengzhe Li, Yigang Tong · 2024 · Microchemical Journal
Antibody Responses to SARS-CoV-2 Following an Outbreak Among Marine Recruits With Asymptomatic or Mild Infection
Irene Ramos, Carl W. Goforth, Alessandra Soares Schanoski, Dawn L. Weir, Emily C Samuels, Shreshta Phogat, Michelle Meyer, Kai Huang, Colette A. Pietzsch, Yongchao Ge et al. · 2021 · Frontiers in Immunology
A rapid assay for SARS-CoV-2 neutralizing antibodies that is insensitive to antiretroviral drugs
De-Li Huang, J. Tran, Linghang Peng, Lin-Lin Yang, Raymond T. Suhandynata, M. Hoffman, Fang-Zhu Zhao, G. Song, Wan-ting He, Oliver Limbo et al. · 2021 · Journal of Immunology
Neutralizing antibody response to SARS-CoV-2 persists 9 months post symptom onset in mild and asymptomatic patients
Olivier Bylicki, D. Delarbre, A. Mayet, Audrey Ferrier, Anne Perisse, Carine Malle, J. Cobola, A. Bronstein, Nastasia Menoud, Elodie Valero-Biance et al. · 2021 · International Journal of Infectious Diseases
Development and multi-center clinical trials of an up-converting phosphor technology-based point-of-care (UPT-POCT) assay for rapid COVID-19 diagnosis and prediction of protective effects
Ping-Ping Zhang, Bai-Sheng Li, Yao Wang, Wei Min, Xiao-Hui Wang, Yu-Gui Zhou, Zhen-Cui Li, Yong Zhao, Huan Zhang, Min Jiang et al. · 2022 · BMC Microbiology
Impact of prior infection status on antibody response to the BNT162b2 mRNA COVID-19 vaccine in healthcare workers at a COVID-19 referral hospital in Milan, Italy
Laura Milazzo, Laura Pezzati, Letizia M Oreni, Cristina Kullmann, Alessia Lai, Arianna Gabrieli, Giovanna Bestetti, Cristian Beschi, Federico Conti, Cosimo Ottomano et al. · 2021 · Human Vaccines & Immunotherapeutics
Temporal trends and differences of SARS-CoV-2-specific antibody responses in symptomatic and asymptomatic subjects: a longitudinal study from Umbria in Italy
Iosief Abraha, Paolo Eusebi, Antonella Germani, Erica Pasquarelli, Sofia Pascolini, Rossana Antonietti, Sandro Argenti, Alessandra Fioravanti, Elisa Martini, Luana Aristei et al. · 2022 · BMJ Open
High SARS-CoV-2 Seroprevalence and Rapid Neutralizing Antibody Decline among Agricultural Workers in Rural Guatemala, June 2020–March 2021
Chelsea Iwamoto, Kelsey E. Lesteberg, Molly M. Lamb, Diva M. Calvimontes, Kejun Guo, Bradley S. Barrett, Kaylee L. Mickens, Lindsey M. Duca, Jose Carlos Monzon, Anna N. Chard et al. · 2022 · Vaccines
Comparative Characterization of Human Antibody Response Induced by BNT162b2 Vaccination vs. SARS-CoV-2 Wild-Type Infection
Theano Lagousi, John G. Routsias, Maria D. Mavrouli, Ioanna Papadatou, Maria Geropeppa, Vana I. Spoulou · 2022 · Vaccines
Physical-Chemical Regulation of Membrane Receptors Dynamics in Viral Invasion and Immune Defense
Rui Qin, Chen-Yi An, Wei Chen · 2022 · Journal of Molecular Biology
Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2
Xiaohui Wei, Na Rong, Jiangning Liu · 2022 · Frontiers in Immunology
COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan
Liang Hong, Xuanxuan Nian, Junzheng Wu, Dong Liu, Lu Zhao Feng, Jia Lu, Yan Peng, Zhijun Zhou, Tao Deng, Jing Liu et al. · 2022 · Cell Discovery
Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19
Charlotte Thibeault, Lara Bardtke, Kanika Vanshylla, Veronica Di Cristanziano, Kirsten Alexandra Eberhardt, Paula Stubbemann, David Hillus, Pinkus Tober‐Lau, Parnika Mukherjee, Friederike Münn et al. · 2023 · JCI Insight
Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao
Hoi Man Ng, Chon Lok Lei, Siyi Fu, Enqin Li, Sek In Leong, Chu Iong Nip, Nga Man Choi, Kai Seng Lai, Xi Tang, Chon Leng Lei et al. · 2023 · Frontiers in Immunology
Ethno‐demographic disparities in humoral responses to the COVID‐19 vaccine among healthcare workers
Pankaj Kumar Ahluwalia, Ashutosh Vashisht, Harmanpreet Singh, Nikhil Sahajpal, Ashis Kumar Mondal, Kimya Jones, Jaspreet Kaur Farmaha, Ryan F. Bloomquist, Caroline Marie Carlock, Drew Fransoso et al. · 2023 · Journal of Medical Virology
Quality Attributes of Ctvad1, A Nanoemulsified Adjuvant for Phase I Clinical Trial of SpiN COVID-19 Vaccine
Bruna Rodrigues Dias Assis, Isabela Pereira Gomes, Júlia Teixeira de Castro, Graziella Gomes Rivelli, Natália Salazar de Castro, Diana Paola Gómez‐Mendoza, Flávia Fonseca Bagno, Natália Satchiko Hojo-Souza, Ana Luiza Chaves Maia, Eduardo Burgarelli Lages et al. · 2023 · Nanomedicine
Contribution of Serological Rapid Diagnostic Tests to the Strategy of Contact Tracing in Households Following SARS-CoV-2 Infection Diagnosis in Children
Lorelei Charbonnier, Julie Roupret‐Serzec, Marion Caséris, Marion Danse, Aurélie Cointe, Laure Cohen, Albert Faye, Naïm Ouldali, Jean Gaschignard · 2021 · Frontiers in Pediatrics
Surrogate test performance for SARS‐CoV ‐2 neutralizing antibodies ( nAbs ) for convalescent plasma ( CCP ): How useful could they be?
Silvano Wendel, Roberta Maria Fachini, Rita Fontão‐Wendel, Ralyria Mello, Carlos Vinícius Velasquez, Rafael Rahal Guaragna Machado, Mayra Brito, Marcelo Amaral, Camila Pereira Soares, Ruth Achkar et al. · 2021 · Transfusion
Persistence of Neutralizing Antibodies to SARS-CoV-2 in First Wave Infected Individuals at Ten Months Post-Infection: The UnIRSA Cohort Study
Gloria Griffante, Shikha Chandel, Daniela Ferrante, Valeria Caneparo, Daniela Capello, Valentina Bettio, Cinzia Borgogna, Chiara Aleni, Salvatore Esposito, Andrea Sarro et al. · 2021 · Viruses
Assessment of the Field Utility of a Rapid Point-of-Care Test for SARS-CoV-2 Antibodies in a Household Cohort
Mehal Churiwal, Kelly Lin, Salman Khan, Srijana Chhetri, Meredith Muller, Kathleen Tompkins, J. W. G. Smith, Christy Litel, Maureen Whittelsey, C. Andrew Basham et al. · 2021 · American Journal of Tropical Medicine and Hygiene
Sterilizing Immunity against SARS‐CoV‐2 Infection in Mice by a Single‐Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist‐Adjuvanted Recombinant Spike Protein Vaccine**
Sonia Jangra, Jana De Vrieze, Angela Choi, Raveen Rathnasinghe, Gabriel Laghlali, Annemiek Uvyn, Simon Van Herck, Lutz Nuhn, Kim Deswarte, Zifu Zhong et al. · 2021 · Angewandte Chemie
Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period
Catherine Lazor‐Blanchet, Panagiota Zygoura, Urania G. Dafni, Frédéric Lamoth, Zoi Tsourti, Michael A. Lobritz, Jean Regina, Bruno Grandbastien, Craig W. Fenwick, Giuseppe Pantaleo et al. · 2022 · Journal of Infection
Safety, tolerability, and antibody response after intradermal vaccination of PFE-BNT in adults who have completed two-doses of Verocell (inactivated vaccine)
Nipon Chalermphanchai, Wachiraporn Arunothong, Niphawan Jettavan, Surin Chanta, Thunthiwa Boonpisitsakul, Monthon Mayoon, Piyawan Lueangchiranothai, Natthawat Yodsurang, Wichai Chanchue, Yupin Tananuchit et al. · 2022 · Vaccine X
Factors affecting the content of Ig G-antibodies to S-protein SARS-CoV-2 in the blood of reconvalescents after new coronaviral infection (COVID-19)
Evgeniy V. Kryukov, В. В. Салухов, Котив Богдан Николаевич, Dmitrii V. Ovchinnikov, Yu. V. Andreychuk, Dmitriy G. Denisov, Аlexey B. Bogomolov, Харитонов Михаил Анатольевич, Yu. V. Rudakov, Садовников Павел Сергеевич et al. · 2022 · Meditsinskiy sovet = Medical Council
Leveraging South African HIV research to define SARS‐CoV ‐2 immunity triggered by sequential variants of concern
Jinal N. Bhiman, Penny L. Moore · 2022 · Immunological Reviews
Long-term antibody response following SPUTNIK V primary vaccination in healthcare workers with and without history of SARS-CoV-2 infection: Prospective cohort study from a hospital in Argentina
Angela S. de Gentile, Vanesa Edelvais Castellano, Anabella Pacchiotti, Natacha Weinberger, Sofía Diana Menéndez, Mariela del Pino, Georgina Carciofi, Patricia Lamy, Alicia Susana Mistchenko · 2022 · Vaccine X
Immunogenicity and safety of the CoronaVac vaccine in patients undergoing treatment for breast and lung cancer
Yakup İriağaç, Eyyüp Çavdar, Kubilay Karaboyun, Okan Avcı, Özkan Alan, Halil Taşkaynatan, Aliye Çelikkol, Sonat Pınar Kara, Berna Erdal, S. Seber · 2022 · Bratislavské lekárske listy/Bratislava medical journal
Neutralizing antibody responses to SARS-CoV-2: A population based seroepidemiological analysis
Pragya Sharma, Ekta Gupta, Saurav Basu, Reshu Agarwal, Suruchi Mishra, Pratibha Ramchandra Kale, Nutan Mundeja, B S Charan, Gautam Kumar Singh, Mongjam Meghachandra Singh · 2022 · Indian Journal of Medical Microbiology
Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples
Max Meyrath, Martyna Szpakowska, Jean‐Marc Plesséria, Olivia Domingues, Jérémie Langlet, Bernard Weber, Rejko Krüger, Markus W. Ollert, Andy Chevigné · 2022 · Methods in enzymology on CD-ROM/Methods in enzymology
A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjects
Jasper de Boer, Ursula Saade, Elodie Granjon, Sophie Trouillet‐Assant, Carla Saade, Hans Pottel, Maan A. Zrein, Covid ser study group · 2022 · PLoS ONE
Persistence of antibody responses to COVID-19 vaccines among participants in the COVID-19 Community Research Partnership
Andrea A. Berry, Ashley Hogan Tjaden, Jone Renteria, DeAnna J. Friedman-Klabanoff, Amy N. Hinkelman, Michael A. Gibbs, Amina Ahmed, Michael S. Runyon, John S. Schieffelin, Roberto Parulan Santos et al. · 2023 · Vaccine X
Kinetics of Neutralizing Antibody Response Underscores Clinical COVID-19 Progression
Qing Lei, Hongyan Hou, Cai-Zheng Yu, Yan-Di Zhang, Jo-Lewis Banga Ndzouboukou, Xiaosong Lin, Zongjie Yao, H. Fu, Zi-Yong Sun, Feng Wang et al. · 2021 · Journal of Immunological Research
Modeling SARS-CoV-2 propagation using rat coronavirus-associated shedding and transmission
Caroline J. Zeiss, Jennifer L. Asher, Brent Vander Wyk, Heather Gwynn Allore, Susan R Compton · 2021 · PLoS ONE
A cohort study measuring SARS-CoV-2 seroconversion and serial viral testing in university students
Christine C. Lee, Hannah E. Segaloff, Devlin Cole, Hannah G. Rosenblum, Clint N. Morgan, Tarah S. Somers, Rodel Desamu-Thorpe, Monique A. Foster, Dustin W. Currie, Jeanne C. Ruff et al. · 2022 · BMC Infectious Diseases
Adaptive immunity to SARS-CoV-2 in cancer patients: The CAPTURE study
Annika Fendler, Lewis Au, Laura Amanda Boos, Fiona Byrne, Scott T.C. Shepherd, Ben Shum, Camille L. Gerard, Barry Ward, Wenyi Xie, Maddalena Cerrone et al. · 2020 · medRxiv
Replication-incompetent VSV-based vaccine elicits protective responses against SARS-CoV-2 and influenza virus
Richard Ayomide Adeleke, Julie Sahler, Annette Choi, Kyle Roth, Viraj Upadhye, Shahrzad Ezzatpour, Brian Imbiakha, Solomiia Khomandiak, Annika N. Diaz, Gary R. Whittaker et al. · 2025 · Science Advances
SARS-CoV-2 Infection in Spondyloarthritis Patients Treated With Biotechnological Drugs: A Study on Serology
Augusta Ortolan, Mariagrazia Lorenzin, Chiara Cosma, Giacomo Cozzi, Andrea Padoan, Andrea Doria, Mario Plebani, Roberta Ramonda · 2021 · Frontiers in Immunology
Assessment of the cellular immunity response to the new coronavirus infection COVID-19
A. V. Lobov, P. I. Ivanova, E. A. Pogodina, Vasily I. Kazey, E. D. Maksimova, Irina Zh. Shubina · 2021 · Russian Journal of Biotherapy
Kinetics and persistence of anti‐SARS‐CoV‐2 neutralisation and antibodies after BNT162b2 vaccination in a Swiss cohort
Lara Šošić, Marta Paolucci, Agathe Duda, Fabio Hasler, Senta M. Walton, Thomas M. Kündig, Pål Johansen · 2021 · Immunity Inflammation and Disease
Measurement of antibody levels in patients with COVID-19 over time by immunofluorescence assay: a longitudinal observational study
Betül Börkü Uysal, Serap Yavuzer, Mehmet Sami İslamoğlu, Mahir Cengız · 2022 · Journal of International Medical Research
Electron microscopy overview of SARS-COV2 and its clinical impact
Soheir S. Mansy, Mona Mahmoud AbouSamra · 2022 · Ultrastructural Pathology
Confirmed reinfection with SARS‐CoV‐2 during a pregnancy: A case report
Verena Sengpiel, Ylva Carlsson, Jan‐Åke Liljeqvist, Anders Elfvin, Ing‐Marie Fyhr, Anna Lundgren, Kristina Nyström, Mats Bemark, Magnus Gisslén, Johan Ringlander · 2022 · Clinical Case Reports
Serologic Tests for COVID-19 Infections and Vaccination
Stanley Alan Plotkin · 2022 · The Pediatric Infectious Disease Journal
SARS-CoV-2 antibody progression and neutralizing potential in mild symptomatic COVID-19 patients – a comparative long term post-infection study
Jessica Brehm, Alexander Spaeth, Lars Dreßler, Thomas Masetto, Rainer Dannenberg, Christoph Peter, Matthias Grimmler · 2022 · Frontiers in Immunology
Some features of the manifestation of the COVID-19 epidemic process on the territory of the Russian Federation at the stage of the ongoing pandemic
Federal State Budgetary Scientific Institution ", Alla Nikolaevna Kaira, , Moscow, Russia, Federal State Budgetary Educational Institution of Additional Professional Education ", of the Ministry of Health of the Russian Federation, Moscow, Russia, Alyona A. Murzina · 2022 · Sanitarnyj vrač (Sanitary Doctor)
The comprehensive insights into the B-cells-mediated immune response against COVID-19 infection amid the ongoing evolution of SARS-CoV-2
Manish K. Dhawan, Nanamika Thakur, Manish Kumar Sharma, Ali Ahmed Rabaan · 2025 · Biomedicine & Pharmacotherapy
Circulating SARS-CoV-2 spike IgG antibody responses in cancer patients following multiple COVID-19 vaccination boosters
Huijing Xue, Troy J. Kemp, Hayley F. North, Nancy Roche, Thomas E. Hickey, Lígia A. Pinto · 2025 · Frontiers in Immunology
Coronavirus Disease 2019 Convalescent Plasma and the Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Titer
Evan M. Bloch, Elizabeth P. Crowe, Aaron A.R. Tobian · 2021 · The Journal of Infectious Diseases
COVID-19 and immunity: quo vadis?
Masayuki Miyasaka · 2021 · International Immunology
Antibody and viral RNA kinetics in SARS-CoV2 infected patients admitted to a Romanian University Hospital of Infectious Diseases
Amanda Lelia Rădulescu, Alexandru Istrate, Mirela Flonta, Mihaela Sorina Lupșe · 2021 · International Journal of Infectious Diseases
The COVID-19 Vaccine in Clinical Trials: Where Are We Now?
Hudachuan Jiang, Jingxin Li, Peng Zhang, X. Huo, F. Zhu · 2021 · Infectious Diseases & Immunity
Quantitative circular flow immunoassays with trained object recognition to detect antibodies to SARS-CoV-2 membrane glycoprotein
Ryan Yuki Huang, Deron Raymond Herr · 2021 · Biochemical and Biophysical Research Communications
The protective immunity induced by SARS-CoV-2 infection and vaccination: a critical appraisal
Eduardo Tosta · 2021 · Exploration of Immunology
Prevalence of SARS-CoV-2 Antibody in 2,935 Healthcare Workers at 6 Major Hospitals, Daegu, Korea
Yu Kyung Kim, Dohsik Minn, Do Young Song, Chae Hoon Lee, Nam Hee Ryoo, Chang‐Ho Jeon, Kyung Eun Song, Jang Soo Suh, Soon Hee Chang · 2021 · Journal of Korean Medical Science
Six-Months Immunogenicity of BNT162b2 mRNA Vaccine in Heart Transplanted and Ventricle Assist Device-Supported Patients
Osnat Itzhaki Ben Zadok, Aviv A. Shaul, Binyamin Ben‐Avraham, Vicky Yaari, Haim Ben Zvi, Noa Eliakim‐Raz, Dafna Yahav, Galia Abed, Miriam Abuhazira, Yaron D. Barac et al. · 2022 · ESC Heart Failure
Trajectory patterns of SARS-CoV-2 neutralising antibody response in convalescent COVID-19 patients
Ngai Sze Wong, Shui Shan Lee, Denise Pui Chung Chan, Timothy C. M. Li, Tracy Hang-Yee Ho, Fion Luk, Kai Ming Chow, Eugene Y. K. Tso, Eng‐Kiong Yeoh, Samuel Yeung Shan Wong et al. · 2022 · Communications Medicine
Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study
Faisal Ali Alasmari, Mahmoud Mukahal, Alaa AlQurashi, Molla M. Huq, Fatima Alabdrabalnabi, Abdullah Nasser AlJurayyan, Shymaa M Alkahtani, Fatimah Salem Assari, Rahaf Bashaweeh, Rana Salam et al. · 2022 · PLoS ONE
Permissive omicron breakthrough infections in individuals with binding or neutralizing antibodies to ancestral SARS-CoV-2
Erin Williams, Jordan Colson, Ranjini Valiathan, Juan Manuel Carreño, Florian Krammer, Michael E. Hoffer, Suresh Pallikkuth, Savita G. Pahwa, David M Andrews · 2022 · Vaccine
RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care Workers
R. Aguilar, Xue Li, C. Crowell, Teresa K. Burrell, M. Vidal, R. Rubio, A. Jiménez, P. Hernández-Luis, D. Hofmann, H. Mijočević et al. · 2023 · Microbiology spectrum
Persistent humoral and CD4+ TH cell immunity after mild SARS-COV-2 infection—The CoNAN long-term study
Clara Schnizer, Nico Andreas, Wolfgang Vivas, Thomas Kamradt, Michael Baier, Michael Kiehntopf, Stefan Glöckner, André Scherag, Bettina Löffler, Steffi Kolanos et al. · 2023 · Frontiers in Immunology
Homology Modeling of Antibody Variable Regions: Methods and Applications
Harsh Bansia, Suryanarayanarao Ramakumar · 2023 · Methods in molecular biology
Persistence of SARS-CoV-2 IgG Antibody Response among South African Adults: A Prospective Cohort Study
Oladele Vincent Adeniyi, Oyewole Christopher Durojaiye, Charity Mandisa Masilela · 2023 · Vaccines
Social Restrictions Versus Testing Campaigns in the COVID-19 Crisis: A Predictive Model Based on the Spanish Case
Francisco Javier Candel, Elisabet Viayna, Daniel Callejo, Raúl Ramos, Jesús San-Román-Montero, Pablo Barreiro, María del Mar Carretero, Adam Kolipiński, Jesús Canora, Antonio Zapatero et al. · 2020 · Viruses
Statins in COVID-19 Therapy
Justyna Olszewska-Parasiewicz, Łukasz Szarpak, Sylwester Rogula, Aleksandra Gąsecka, Urszula A. Szymańska, Maria Kwiatkowska, Milosz Jaroslaw Jaguszewski, Radosław Sierpiński, Artur Zaczyński, Waldemar Wierzba et al. · 2021 · Life
Revised recommendations from the CSO-HNS taskforce on performance of tracheotomy during the COVID-19 pandemic – what a difference a year makes
Doron D. Sommer, David W. J. Côté, Tobial McHugh, Martin J. Corsten, Marc A. Tewfik, Seyedeh Fatemeh Sadati Khalili, K. Fung, M. Gupta, Niv Sne, Paul T. Engels et al. · 2021 · Journal of Otolaryngology - Head and Neck Surgery
Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study
M. Provencio, D. Rodríguez-Abreu, A. L. Ortega, G. Serrano, C. Aguado, F. Franco, V. Gutiérrez, Guillermo López Vivanco, M. Guirado, G. Benítez et al. · 2021 · Translational Lung Cancer Research
Evaluación de la respuesta humoral inducida por la vacuna BBIBP-CorV mediante la determinación de anticuerpos neutralizantes en personal sanitario peruano
Alonso Soto, Flor de Maria Charca-Rodriguez, Mario Pareja-Medina, Manuel Fernández-Navarro, Karina Altamirano-Cáceres, Elizett Sierra Chávez, Jarvis Raraz-Vidal, Néstor E. Cabezudo-Pillpe, Melissa Velarde-Rodríguez, Andrés Martín Alcántara-Díaz · 2021 · Revista Peruana de Medicina Experimental y Salud Pública
Assessing humoral immune response after two doses of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthcare workers
Hadiye Demirbakan, İpek Koçer, M. Erdoğan, Ayşen Bayram · 2022 · Public Health
SARS-CoV-2 RBD-specific and NP-specific antibody response of healthcare workers in the westernmost Austrian state Vorarlberg: a prospective cohort study
Michele Atzl, Axel Muendlein, Thomas L. Winder, Peter Fraunberger, Eva‐Maria Brandtner, Kathrin D. Geiger, Miriam Klausberger, Mark Duerkop, Lukas Sprenger, Beatrix Mutschlechner et al. · 2022 · BMJ Open
Reduced neutralization against Delta, Gamma, Mu, and Omicron BA.1 variants of SARS-CoV-2 from previous non-Omicron infection
Paola Pidal, Jorge Onrubia Fernández, Constanza Airola, Miguel Araujo, Ana María Menjiba, Héctor San Martín, Nicole Bruneau, Monserrat Balanda, Coral Elgueta, Rodrigo Fasce et al. · 2022 · Medical Microbiology and Immunology
A New Saliva-Based Lateral-Flow SARS-CoV-2 IgG Antibody Test for mRNA Vaccination
Dingying Shan, Jessica Hsiung, Kevin P. Bliden, Su Zhao, Tao Liao, Guoxing Wang, Shuanglin Tan, Tiancheng Liu, Deepika Sreedhar, Jessica Kost et al. · 2021 · medRxiv
Bivalent mRNA vaccine improves antibody-mediated neutralization of many SARS-CoV-2 Omicron lineage variants
Nannan Jiang, Li Wang, Masato Hatta, Chenchen Feng, Michael Currier, Xudong Lin, Jaber Hossain, Dan Cui, Brian R. Mann, Nicholas A. Kovacs et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Microfluidic Diffusional Sizing (MDS) Measurements of Secretory Neutralizing Antibody Affinity Against SARS-CoV-2
Cara O'Mahoney, Ian N. Watt, Sebastian Fiedler, Sean R. A. Devenish, Sujata Srikanth, Erica Justice, Tristan Dover, Delphine M. D. Dean, Congyue Annie Peng · 2024 · Annals of Biomedical Engineering
Compound Impacts of COVID-19 mRNA Vaccination and SARS-CoV-2 Infection: A Convergence of Diverse “Spikeopathies” and Other Hybrid Harms
M. Nathaniel Mead, Jessica Rose, Stephanie Seneff, Claire Rogers, Nicolas Hulscher, Kirstin Cosgrove, Breanne Craven, Paul Ellis Marik, Peter A. McCullough · 2025 · Medical Research Archives
Convalescent plasma for COVID ‐19: Donor demographic factors associated high neutralising antibody titres
Jennifer Mehew, Rachel Johnson, David J. Roberts, Alex Griffiths, Heli Harvala · 2022 · Transfusion Medicine
Differential persistence of neutralizing antibody against SARS-CoV-2 in post immunized Bangladeshi population
Dipa Rani Roy, Md. Mosfequr Rahman, Arnaba Saha Chaity, Md Abu Reza, Ariful Haque · 2022 · Scientific Reports
Creation of collective immune as the main preventive measure for the spread of the new coronavirus infection (COVID-19)
Anna Тоvanova · 2022 · Vestnik of Saint Petersburg University Medicine
Comparative Longitudinal Serological Study of Anti-SARS-CoV-2 Antibody Profiles in People with COVID-19
Marilou H. Barrios, Suellen R Nicholson, Rowena Anne Bull, Marianne Martinello, William D. Rawlinson, Michael Mina, Jeffrey John Post, Bernard J. Hudson, Nicole M. Gilroy, Andrew R. Lloyd et al. · 2023 · Microorganisms